ALK-Abelló Logo

ALK-Abelló

A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.

ALK | CO

Overview

Corporate Details

ISIN(s):
DK0061802139
LEI:
529900SGCREUZCZ7P020
Country:
Denmark
Address:
Bøge Alle 6-8, 2970 Hørsholm

Description

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-19 22:46
Selskabsmeddelelse_19_25DK_19122025_Storaktionærmeddelelse-da_14fa89ea-963c-4a6…
Danish PDF 293.1 KB
2025-12-19 22:46
ALKAbello-1001146003-da_b2ef2e45-f05f-4b31-8e3b-9104d7a7dd08.html (Danish)
Danish HTML 2.2 KB
2025-12-19 22:46
Company release_19_25UK_191225_Major shareholder announcement-en_6d01737f-d8f4-…
English PDF 295.5 KB
2025-12-19 22:46
ALKAbello-1001146003-en_f88282d2-ccc7-4931-ba62-912246101444.html (English)
Danish HTML 2.2 KB
2025-11-12 17:17 Danish PDF 102.5 KB
2025-11-12 17:17 Danish HTML 3.3 KB
2025-11-12 17:17 English PDF 104.1 KB
2025-11-12 17:17 English HTML 2.8 KB
2025-09-17 09:44 Danish PDF 174.5 KB
2025-09-17 09:44 Danish HTML 10.0 KB
2025-09-17 09:44 English HTML 8.9 KB
2025-09-17 09:44 English PDF 274.6 KB
2025-08-21 07:30 English HTML 11.5 KB
2025-08-21 07:30 English PDF 505.8 KB
2025-08-21 07:30 English PDF 505.8 KB

Automate Your Workflow. Get a real-time feed of all ALK-Abelló filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ALK-Abelló

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ALK-Abelló via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.